Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Ekaterina S. Kotova, Olga A. Gavrilina, MDPhD, Igor A Yakutik, PhD, Andrey B. Sudarikov, PhD DSc, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Galina A. Isinova, MD PhD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141804

Published: 2020

Journal Articles

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Kseniia I. Zarubina, Elena N. Parovichnikova, MD PhD, Vadim L. Surin, Olesya S. Pshenichnikova, PhD, Ekaterina Y. Demidova, PhD, Bella V. Biderman, PhD, Andrey B. Sudarikov, PhD DSc, Galina A. Baskhaeva, MD PhD, Olga A. Gavrilina, MDPhD, Ekaterina S. Kotova, Andrey N. Sokolov, MD PhD, Vera V. Troitskaya, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-136041

Published: 2020

Journal Articles

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-138504

Published: 2020

Journal Articles

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina V. Kokhno, MD PhD, Zalina T. Fidarova, MD PhD, Olga A. Gavrilina, MD PhD, Tatiana I. Lobanova, MD, Elena O. Gribanova, MD PhD, Sergey K. Kravchenko, MD PhD, Gennadiy M. Galstyan, MD PhD, Sergei M. Kulikov, PhD, Julia A. Chabaeva, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5136.

https://doi.org/10.1182/blood-2019-124056

Published: 2019

Journal Articles

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Vera V. Troitskaya, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD PhD, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5183.

https://doi.org/10.1182/blood-2019-128650

Published: 2019

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Elena Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Tatiana I. Lobanova, MD, Yuliya O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD, Alina V. Kokhno, MD, PhD, Roman V. Tivikov, MD, Irina A. Lukyanova, MD, Tatiana N. Obukhova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 1495.

https://doi.org/10.1182/blood-2018-99-116581

Published: 2018

Journal Articles

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

Anastasia V. Abramova, MD, Elena A. Mikhaylova, MD PhD Prof, Zalina T. Fidarova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana I. Lobanova, MD, Anton V. Luchkin, MD, Alina E. Krasilnikova, Resident Physician, Roman V. Tivikov, MD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2018-99-119414

Published: 2018

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Anton V. Luchkin, MD, Elena A. Mikhaylova, MD PhDProf, Zalina T. Fidarova, MD PhD, Anastasia V. Abramova, MD, Vera V. Troitskaya, MD PhD, Tatiana I. Lobanova, MD, Alina E. Krasilnikova, Resident Physician, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana N. Obukhova, MD PhD, Lubov Grebenyuk, MD, Murat Vagida, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2018-99-118738

Published: 2018

Journal Articles

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

Aleksei Bazhenov, MD, Elena N. Parovichnikova, MD PhD, Gennadiy M. Galstyan, MD PhD, Vera V. Troitskaya, MD PhD, Elena O. Gribanova, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5898.

https://doi.org/10.1182/blood-2018-99-116114

Published: 2018

Journal Articles

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Tatiana I. Lobanova, MD, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Vera V. Troitskaya, MD PhD, Irina A. Lukyanova, MD, Elena Parovichnikova, MD PhD, Sergei M. Kulikov, PhD, Larisa Kuzmina, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 2808.

https://doi.org/10.1182/blood-2018-99-114669

Published: 2018

Journal Articles

Human Herpes-Virus 6 Infection in Immunocompromised Patients after Chemotherapy and Autologous Stem Cell Transplantation

Tatiana I. Lobanova, MD, Dmitry S. Tikhomirov, PhD, Olga A. Gavrilina, MDPhD, Zalina T. Fidarova, MDPhD, Galina A. Kliasova, Vladimir A. Okhmat, Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 1013.

https://doi.org/10.1182/blood.V130.Suppl_1.1013.1013

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Andrey N. Sokolov, MD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, Sergei M. Kulikov, PhD, Sergey N. Bondarenko, PhDMD, Julia O. Davidova, Nikolay M. Kapranov, Irina A. Lukyanova, MD, Tatiana I. Lobanova, MD, Ekaterina I. Usikova, MD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3884.

https://doi.org/10.1182/blood.V130.Suppl_1.3884.3884

Published: 2017

Journal Articles

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Anna A. Sidorova, MD, Gennadii M. Galstian, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Anton Olenev, Olga Korobitsyna, Alexandr Korobkin, MD, Elena Kirillova, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 4665.

https://doi.org/10.1182/blood.V130.Suppl_1.4665.4665

Published: 2017

Journal Articles

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey N. Bondarenko, PhDMD, Valery Lapin, Tatiana N. Obukhova, MD PhD, Andrey Sudarikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 2714.

https://doi.org/10.1182/blood.V130.Suppl_1.2714.2714

Published: 2017

Journal Articles

Optimal Dose Horse Antithymocyte Globulin for the Treatment of Adult Patients with Aplastic Anemia: A Prospective Randomized Comparative Study

Zalina T. Fidarova, MDPhD, Elena A. Mikhaylova, MDPhDProf, Elena N. Ustinova, PhD, Vera V. Troitskaya, MD PhD, Anastasia V. Abramova, MD, Anna A. Sidorova, MD, Galina Baskhaeva, MD, Tatiana I. Lobanova, MD, Ksenija I. Zarubina, MD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 4957.

https://doi.org/10.1182/blood.V130.Suppl_1.4957.4957

Published: 2017

Journal Articles

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Vera V. Troitskaya, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5087.

https://doi.org/10.1182/blood.V130.Suppl_1.5087.5087

Published: 2017

Journal Articles

The Frequency and Impact of IKZF1 Deletions on Minimal Residual Disease in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated in Russian Acute Lymphoblastic Leukemia Study

Galina Baskhaeva, MD, Bella V. Biderman, PhD, Julia O. Davydova, Olga A. Gavrilina, MDPhD, Ksenija I. Zarubina, MD, Elena Stepanova, Irina A. Lukyanova, MD, Vera V. Troitskaya, MD PhD, Andrey Sudarikov, PhD, Irina V. Galtseva, MD PhD, Elena N. Parovichnikova, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5002.

https://doi.org/10.1182/blood.V130.Suppl_1.5002.5002

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Andrey N. Sokolov, MD PhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, MD PhD, Julia O. Davidova, Nikolai M. Kapranov, Tatiana N. Obukhova, PhD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 4024.

https://doi.org/10.1182/blood.V128.22.4024.4024

Published: 2016

NARROW

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

The MRD-Negativity Rate Measured By Flow Cytometry after the 1 st and the 2 nd Induction Course Among CR AML Patients from Different Cytogenetic Subgroups Does Not Differ Though the Morphological CR Achievement Does

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

Different Treatment Regimens, Optimal Time Points and Threshold Level While Minimal Residual Disease Evaluation in AML Patients

Human Herpes-Virus 6 Infection in Immunocompromised Patients after Chemotherapy and Autologous Stem Cell Transplantation

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Optimal Dose Horse Antithymocyte Globulin for the Treatment of Adult Patients with Aplastic Anemia: A Prospective Randomized Comparative Study

Absolute Lymphocyte Count after First Induction Is Associated with Relapse Free Survival in Acute Myeloid Leukemia

The Frequency and Impact of IKZF1 Deletions on Minimal Residual Disease in Adult Ph-Negative B-Cell Acute Lymphoblastic Leukemia Patients Treated in Russian Acute Lymphoblastic Leukemia Study

Blinatumomab + Tyrosine Kinase Inhibitors in the Treatment of Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Patients - Clinical Efficacy and Peripheral Blood Lymphocytes Subpopulations Kinetics

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only